Skip to content

Geron

US · GERN #3440 by market cap
0.87 -0.04 -4.63%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 0.90 -1.42%
After-hours 0.89 +2.45%
Overnight 0.91 0.00%
1.630.870.872026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on GERN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -32.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 10.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C-

The radar needs all six factors. Available grades are shown below.

Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 20.5x Better than 35%
Price / Sales 2.9x Better than 44%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 97.4% Better than 99%
Operating margin -28.0% Better than 11%
Net margin -45.4% Better than 9%
Return on equity -33.0% Better than 12%
Return on invested capital -18.4% Better than 14%
Momentum D

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -42.8% Better than 9%
6-month return -32.0% Better than 17%
12-month return (ex latest month) 0.0% Better than 34%
Distance below 52-week high 56.7% Better than 13%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.7x Better than 84%
Debt to assets 21.4% Better than 54%
Interest coverage -1.6x Better than 21%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 75.0% Better than 51%
Upside to average target 339.9% Better than 98%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -10.31%
1M -29.84%
3M -43.87%
6M -30.95%
YTD -34.09%
1Y -20.91%
3Y -56.72%
5Y -43.51%

Key statistics

Price & volume

Prev close
0.91
Open
0.89
Day range
0.86 - 0.93
Avg price
0.90
Volume
13.83M
Turnover
12.39M
Amplitude
6.96%
52-week range
0.84 - 2.01

Valuation

P/E
-6.70
P/E (TTM)
-10.88
P/B
2.47
EPS
-0.13
Net profit
-83.75M
Net assets
226.77M

Share structure

Market cap
560.94M
Float cap
482.46M
Shares out
644.24M
Float shares
554.11M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 3% of range
0.84 2.01

56.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-14.80M net over the window

Short interest

Shares short
66.95M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Geron (GERN)?

Geron last traded at 0.87. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Geron's market cap?

About 560.94M.

What is the P/E ratio of Geron?

The trailing twelve-month P/E is -10.88. The Valuation tab shows it against the stock's own five-year range.

Does Geron pay a dividend?

Geron does not currently pay a regular dividend.

Is Geron a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 3.83, which implies 339.9% upside from the current price. This is not investment advice.

What is Geron's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Geron a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Geron discussion 0 comments

Add a comment